GMO strengthens equities line-up
Global investment management firm GMO has appointed three senior investment professionals to its Sydney-based Australian equities team.
Geoff Wells, Mark Thompson and Bradley Grehan are intended to “strengthen GMO’s global portfolio management, research and trading efforts”, according to GMO’s head of Australian equities Rick Suvak.
Formerly a senior portfolio manager at Macquarie Investment Management, Wells has been appointed as a senior quantitative research analyst, focusing primarily on alpha model research.
Thompson has also joined GMO as senior quantitative research analyst, and will also be concentrating on alpha model research.
He was previously a quantitative portfolio manager at State Street Global Advisors where he managed the group’s short enabled strategies (market-neutral, equitised long-short and 130/30 portfolios).
Grehan joins GMO as a senior portfolio trader, and will focus on trade execution while also participating in the management of GMO’s Australian equity portfolios.
He brings 12 years of industry and trading experience to GMO from Tolhurst, Morgan Stanley and JBWere.
Recommended for you
AUSIEX has announced it will acquire FIIG, a specialist fixed income provider with $4.5 billion in funds under advice.
Platinum Asset Management has announced it is in discussions with a global alternatives fund manager regarding a possible merger to create an $18 billion firm.
Frontier Advisors has bolstered its Japanese footprint through a partnership with the $350 billion asset management arm of Nippon Life Insurance Company.
JP Morgan Asset Management has appointed an ETF specialist from Vanguard as it seeks to expand its ETF range.
